GSE217115 3 V 5 ALECTINIB MOUSE UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE217115 3 V 5 ALECTINIB MOUSE UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE217115 3 V 5 ALECTINIB MOUSE UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE217115 3 V 5 ALECTINIB MOUSE UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE217115 3 V 5 ALECTINIB MOUSE UP.

Results found

Linked to

 

Label

Description

 

Gene

leukocyte receptor cluster member 9

Gene

mitochondrial rRNA methyltransferase 1

Gene

dual specificity phosphatase 13A

Gene

transmembrane protein 238 like

Gene

small integral membrane protein 40

Gene

thioredoxin domain containing 15

Gene

PDZ domain containing 4

Gene

twist family bHLH transcription factor 2

Gene

WD repeat containing planar cell polarity effector

Gene

attractin like 1

  • Gene

    leukocyte receptor cluster member 9


  • Gene

    mitochondrial rRNA methyltransferase 1


  • Gene

    dual specificity phosphatase 13A


  • Gene

    transmembrane protein 238 like


  • Gene

    small integral membrane protein 40


  • Gene

    thioredoxin domain containing 15


  • Gene

    PDZ domain containing 4


  • Gene

    twist family bHLH transcription factor 2


  • Gene

    WD repeat containing planar cell polarity effector


  • Gene

    attractin like 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.